Kumar Budur - 01 May 2025 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Christian Ulrich, Attorney-in-Fact
Issuer symbol: HRMY
Transactions as of: 01 May 2025
Net transactions value: -$264,828
Form type: 4
Filing time: 09 May 2025, 16:07:59 UTC
Previous filing: 28 Jan 2025
Next filing: 26 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Budur Kumar	CHIEF MEDICAL OFFICER	630 W GERMANTOWN PIKE, PLYMOUTH MEETING	/s/ Christian Ulrich, Attorney-in-Fact	09 May 2025	0002009762

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HRMY	Common Stock	Options Exercise	$0	+18,750		$0.000000	18,750	01 May 2025	Direct
transaction	HRMY	Common Stock	Tax liability	$264,828	-8,869	-47%	$29.86	9,881	01 May 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRMY	Restricted Stock Units	Options Exercise	$0	-18,750	-50%	$0.000000	18,750	01 May 2025	Common Stock	18,750		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
F2	The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.